2026 Mars Shot Grant - Early Detection of Prostate Cancer
Forecasted
2026 Mars Shot Grant - Early Detection of Prostate Cancer supports researchers studying early detection of low- to intermediate-risk disease through nuclear medicine to improve patient management and quality of life.
Browse similar grants
Funder: Society of Nuclear Medicine and Molecular Imaging
Due Dates (Anticipated): June 2027 (Application deadline) | September 2027 (Extended application deadline)
Funding Amounts: $100,000
Summary: Supports nuclear medicine research on early detection of low- to intermediate-risk prostate cancer to improve patient management, survival, and quality of life.
Key Information: The principal investigator must be an active SNMMI member.
Description
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) offers this grant through its Mars Shot Research Fund to support nuclear medicine research focused on early detection of prostate cancer. Proposed work must address patients with low- to intermediate-risk disease: Grade Groups 1 and 2, corresponding to Gleason scores 6 and 7 (3+4). The goal is to benefit patient management, with potential improvements in overall survival and quality of life.
The Mars Shot Research Fund supports the translation of visionary nuclear medicine imaging, radiopharmaceutical therapy, and data science research into tools or treatments that improve patients’ lives. This opportunity addresses a disease affecting more than 300,000 men annually in the United States and accounting for approximately 35,000 deaths each year.
